We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline include... Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline includes Glioblastoma Multiforme (GBM); Radiation Dermatitis and Chemotherapy-Induced Peripheral Neuropathy (CIPN). Show more
New patents provide additional composition of matter and methods of use claims for Envericās EVM301 series neuroplastogenic molecules, and recently out-licensed tryptamine-derived prodrugs...
Dose-proportional oral bioavailability without clinical signs, including those associated with hallucinogenic compounds, was demonstrated in rat and dog pharmacokinetic (PK) studies while...
Advanced pre-IND activities and research for lead candidate, EB-003, a novel neuroplastogenic molecule designed to treat severe mental health disorders Announced the expansion of patent...
Agreement includes development and sales milestones payments potentially totaling up to $62 million as well as tiered single digit royalties on future sales Enveric Biosciences, Inc. (NASDAQ:...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0093 | 2.86771507863 | 0.3243 | 0.3522 | 0.3036 | 301939 | 0.32765964 | CS |
4 | -0.1444 | -30.2092050209 | 0.478 | 0.525 | 0.3036 | 325063 | 0.39837121 | CS |
12 | -0.1829 | -35.4114230397 | 0.5165 | 0.555 | 0.3036 | 564893 | 0.43482861 | CS |
26 | -0.4543 | -57.6596014723 | 0.7879 | 0.7979 | 0.3036 | 830226 | 0.52393919 | CS |
52 | -1.1964 | -78.1960784314 | 1.53 | 2.92 | 0.3036 | 1626499 | 1.12128056 | CS |
156 | -0.9264 | -73.5238095238 | 1.26 | 14.87 | 0.1551 | 1381079 | 1.66537667 | CS |
260 | -5.6664 | -94.44 | 6 | 14.87 | 0.1551 | 1882138 | 2.46728668 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions